Cerity Partners LLC Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Cerity Partners LLC lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 62,438 shares of the exchange traded fund’s stock after selling 19,810 shares during the quarter. Cerity Partners LLC owned about 0.08% of SPDR S&P Biotech ETF worth $5,575,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in XBI. Resources Management Corp CT ADV lifted its position in SPDR S&P Biotech ETF by 1,715.8% during the 2nd quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after acquiring an additional 326 shares during the period. Tyler Stone Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $33,000. EPG Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 152.7% during the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after acquiring an additional 278 shares during the period. Compass Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $34,000. Finally, Fortis Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $38,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $85.62 on Wednesday. The business has a 50 day simple moving average of $93.86 and a 200-day simple moving average of $84.12. The stock has a market capitalization of $6.65 billion, a P/E ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.